FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Pharmacy Plus, Inc. dba Vital Care Compounder C-Semaglutide 5mg/mL injection Recall

C-Semaglutide 5mg/mL injection, 0

Pharmacy Plus, Inc. dba Vital Care Compounder · Hattiesburg, MS

Risk level
Class II
Reported by FDA
Apr 26, 2023
Recall ID
D-0538-2023
Check your lot numberHow we source this data

Summary

Pharmacy Plus, Inc. dba Vital Care Compounder recalled C-Semaglutide 5mg/mL injection starting Apr 13, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0538-2023 on Apr 26, 2023. Reason: Lack of assurance of sterility. Status: Ongoing.

Why it was recalled

Lack of assurance of sterility.

Product description

C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402

Lot numbers, UPCs & expiration codes

Lot #: 73810, Exp. Date 5/1/2023

Where it was sold

MS only

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0538-2023
Classification
Class II
Status
Ongoing
Recall initiated
Apr 13, 2023
FDA report date
Apr 26, 2023
Quantity
45 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Pharmacy Plus, Inc. dba Vital Care Compounder

Original FDA data

Every field from FDA enforcement report D-0538-2023, exactly as published.

Show all FDA fields
City
Hattiesburg
State
MS
Status
Ongoing
Country
United States
Event ID
92121
Address
115 S 40th Ave
Code information
Lot #: 73810, Exp. Date 5/1/2023
Postal code
39402-6600
Report date
Apr 26, 2023
Product type
Drugs
Recall number
D-0538-2023
Classification
Class II
Recalling firm
Pharmacy Plus, Inc. dba Vital Care Compounder
Product quantity
45 vials
Reason for recall
Lack of assurance of sterility.
Voluntary / mandated
Voluntary: Firm initiated
Product description
C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402
Distribution pattern
MS only
Recall initiation date
Apr 13, 2023
Initial firm notification
Telephone
Center classification date
Apr 19, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0538-2023, published Apr 26, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls